Mounjaro (Tirzepatide) is a weekly injectable GLP-1 and GIP receptor agonist medication FDA approved for Chronic Weight Management (2023) and for Type 2 Diabetes (2022).
Weight Loss Book (pdf)
Download912-295-5560
119 Chimmey Road, Rincon, Georgia 31326, United States
Open today | 08:30 am – 07:00 pm |
We use cookies to analyze website traffic and optimize your website experience. By accepting our use of cookies, your data will be aggregated with all other user data.
Botox available April 30th
$10 a unit
By appointment only
Call office for more details